scispace - formally typeset
L

Linda Kvastad

Researcher at Royal Institute of Technology

Publications -  15
Citations -  182

Linda Kvastad is an academic researcher from Royal Institute of Technology. The author has contributed to research in topics: Medicine & Multiplex ligation-dependent probe amplification. The author has an hindex of 5, co-authored 10 publications receiving 90 citations.

Papers
More filters
Journal ArticleDOI

Spatially resolved clonal copy number alterations in benign and malignant tissue

TL;DR: In this paper , the authors used spatially resolved transcriptomics to infer spatial copy number variations in 120,000 regions across multiple organs, in benign and malignant tissues, and demonstrate that genome-wide copy number variation reveals distinct clonal patterns within tumours and in nearby benign tissue using an organ-wide approach focused on the prostate.
Journal ArticleDOI

Multiplex PCB-based electrochemical detection of cancer biomarkers using MLPA-barcode approach.

TL;DR: The optimised MLPA system was demonstrated to be highly specific with negligible cross-reactivity allowing the simultaneous detection of the seven mRNA markers, with limits of detections as low as 25pM.
Journal ArticleDOI

Single cell analysis of cancer cells using an improved RT-MLPA method has potential for cancer diagnosis and monitoring

TL;DR: A highly sensitive method for detecting and quantifying a panel of seven genes whose expression patterns are associated with breast cancer, and optimized the method for single cell analysis supports the use of RT-MLPA as a diagnostic tool for cancer genomics.
Posted ContentDOI

Genome-wide Spatial Expression Profiling in FFPE Tissues

TL;DR: This work conducted expression profiling and cell type mapping in coronal sections from the mouse brain to demonstrate the method’s capability to delineate anatomical regions from a molecular perspective and explored the spatial composition of transcriptomic signatures in ovarian carcinosarcoma samples using data driven analysis methods.
Journal ArticleDOI

CCL2 mediates anti-fibrotic effects in human fibroblasts independently of CCR2.

TL;DR: Surprisingly, it is found that CCL2 mediates anti-fibrotic effects independently of CCR2 in human fibroblasts of different origins.